Antitrust Antitrust

Covid-19 impact not deemed a legitimate factor for SAMR to lower antitrust fines

By Yonnex Li
  • 11 May 2020 01:26
  • 11 May 2020 01:26
China's antitrust regulator doesn't consider the economic hardship brought about by the Covid-19 epidemic as a legitimate mitigating factor to reduce fines for confirmed antitrust violations, MLex has learned.

The State Administration for Market Regulation, or SAMR, isn't empowered to factor in the epidemic because it is not among the statutory circumstances stipulated

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

TAKE A FREE TRIAL

Latest News